Ascendia Pharmaceutical Solutions announced that the 4th annual two-day technical workshop Advances in Innovative Technologies for Formulation & Delivery of Molecules is being held on September 15-16, 2026 at the Crowne Plaza Princeton - Conference Center, with Michael Lowinger leading a discussion on Digital Solutions Driving Insights and Rigor into Complex Drug Product Development.
Published
Signal category
Presence & Recognition
Quote
“Our list of speakers at the Ascendia Pharmaceutical Solutions 4th annual two-day technical workshop, Advances in Innovative Technologies for Formulation & Delivery of Molecules, is long and impressive.”
— Ascendia Pharmaceutical Solutions team
Company
Ascendia Pharmaceutical Solutions
Making the Impossible Possible
- Industry
- Pharmaceutical Manufacturing
- Location
- North Brunswick, US
- Company size
- 87 employees
Based in North Brunswick, New Jersey, Ascendia Pharmaceutical Solutions is a specialty contract development and manufacturing (CDMO) company dedicated to delivering sophisticated formulations of existing drug products, and enabling formulations for preclinical- and clinical-stage drug candidates. Ascendia Pharmaceutical Solutions is your ideal partner for: • Pre-formulation services/screening • Formulation development • Proprietary nanotechnologies • ICH stability studies • Sterile and non-sterile manufacturing • Analytical services, QC and Micro testing • Clinical trial material supply • Niche commercial product manufacturing
Founded 2012